INE750C01026
INE750C01026
MARKSANS PHARMA LIMITED
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 140.07B EUR | 123.56B EUR | 71.1B EUR | 81.64B EUR |
Enterprise Value | 133.89B EUR | 123.56B EUR | 68.19B EUR | 81.64B EUR |
Valuation Multiples | ||||
Trailing P/E | 27.09x | 23.91x | 17.01x | 30.26x |
Forward P/E | 21.97x | -- | -- | -- |
Price to Sales | 4.42x | 3.9x | 2.41x | 3.9x |
Price to Book | 4.63x | -- | 2.35x | -- |
EV/Revenue | 4.22x | 3.9x | 2.31x | 3.9x |
EV/EBITDA | 19.77x | 15.14x | 9.98x | 18.03x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |